VA

VR Adviser Portfolio holdings

AUM $1.33B
This Quarter Return
+25.35%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$1.91B
AUM Growth
+$1.91B
Cap. Flow
+$23.6M
Cap. Flow %
1.23%
Top 10 Hldgs %
65.6%
Holding
38
New
3
Increased
6
Reduced
6
Closed
–

Top Buys

1
ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
$73.9M
2
ARTV
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$24.9M
3
CASI icon
CASI Pharmaceuticals
CASI
$5.39M
4
ENGN icon
enGene Holdings
ENGN
$4.88M
5
APLT icon
Applied Therapeutics
APLT
$2.4M

Top Sells

1
EWTX icon
Edgewise Therapeutics
EWTX
$21.8M
2
MRUS icon
Merus
MRUS
$17.7M
3
ZURA icon
Zura Bio
ZURA
$16.2M
4
DNTH icon
Dianthus Therapeutics
DNTH
$9.58M
5
ARVN icon
Arvinas
ARVN
$4.27M

Sector Composition

1 Healthcare 99.61%
2 Financials 0.39%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TSHA icon
26
Taysha Gene Therapies
TSHA
$791M
$18.1M 0.95%
9,000,000
– –
ABVX
27
Abivax
ABVX
$6.32B
$15.5M 0.81%
1,345,780
– –
TRVI icon
28
Trevi Therapeutics
TRVI
$871M
$11.4M 0.6%
3,422,656
+19
+0% +$63
ARVN icon
29
Arvinas
ARVN
$580M
$11.2M 0.59%
454,450
-173,338
-28% -$4.27M
ADVM icon
30
Adverum Biotechnologies
ADVM
$68.2M
$10.3M 0.54%
1,467,048
– –
IPSC icon
31
Century Therapeutics
IPSC
$40.4M
$9.22M 0.48%
5,389,259
– –
ZURA icon
32
Zura Bio
ZURA
$132M
$8.21M 0.43%
2,023,166
-4,000,000
-66% -$16.2M
PCSC
33
Perceptive Capital Solutions Corp Class A Ordinary Shares
PCSC
$117M
$7.52M 0.39%
750,000
– –
CABA icon
34
Cabaletta Bio
CABA
$144M
$7.38M 0.39%
1,563,952
– –
CASI icon
35
CASI Pharmaceuticals
CASI
$36.1M
$6.08M 0.32%
987,259
+875,573
+784% +$5.39M
TNYA icon
36
Tenaya Therapeutics
TNYA
$192M
$3M 0.16%
1,555,556
– –
TIL icon
37
Instil Bio
TIL
$196M
$2.23M 0.12%
+33,177
New +$2.23M
TENX icon
38
Tenax Therapeutics
TENX
$27.5M
$721K 0.04%
+208,333
New +$721K
1
2